Outcomes of Transcutaneous Retrobulbar Amphotericin B in Rhino-Orbital-Cerebral Mucormycosis Among Patients Recovering From COVID-19: A Preliminary Experience

Background In this study, we aimed to assess the outcomes of transcutaneous retrobulbar injection of amphotericin B (TRAMB) in rhino-orbital-cerebral mucormycosis (ROCM) among patients recovering from coronavirus disease 2019 (COVID-19). Methodology This retrospective study was conducted at a tertia...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Shivani, Kumar, Vidya B, Kumar, Abhay, Singh, Vivek, Anand, Abhishek, Kusumesh, Rakhi, Mishra, Sarita, Raj, Pragati, Sinha, Bibhuti P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455078/
https://www.ncbi.nlm.nih.gov/pubmed/36106303
http://dx.doi.org/10.7759/cureus.27817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455078/
https://www.ncbi.nlm.nih.gov/pubmed/36106303
http://dx.doi.org/10.7759/cureus.27817

Ejemplares similares